apnea has been researched along with Complete Trisomy 18 Syndrome in 4 studies
Apnea: A transient absence of spontaneous respiration.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Central apnea is a major cause of death in neonates with trisomy 18 (T18) and is likely due to immaturity of the respiratory drive, similar to the pathological mechanism in apnea of prematurity." | 8.12 | Caffeine for the Treatment of Central Apnea in Trisomy 18: A Case Study in the Novel Use of Methylxanthines in Palliative Transport. ( Andersen, L; Ariagno, S; Collura, C; Thorvilson, M, 2022) |
| "This case series aimed to characterize the clinical features, management, and outcomes of apnea in infants with trisomy 18." | 7.96 | Management of apnea in infants with trisomy 18. ( Fujiyoshi, J; Ichimiya, Y; Inoue, H; Ochiai, M; Ohga, S; Sakai, Y; Sanefuji, M; Sawano, T; Taira, R; Torio, M, 2020) |
| "Many children with trisomy 18 have apneas from the neonatal period." | 7.81 | Apneas observed in trisomy 18 neonates should be differentiated from epileptic apneas. ( Asada, H; Fukasawa, T; Hattori, T; Kato, Y; Kubota, T; Matsusawa, K; Negoro, T; Tanaka, M, 2015) |
| "Central apnea is a major cause of death in neonates with trisomy 18 (T18) and is likely due to immaturity of the respiratory drive, similar to the pathological mechanism in apnea of prematurity." | 4.12 | Caffeine for the Treatment of Central Apnea in Trisomy 18: A Case Study in the Novel Use of Methylxanthines in Palliative Transport. ( Andersen, L; Ariagno, S; Collura, C; Thorvilson, M, 2022) |
| "This case series aimed to characterize the clinical features, management, and outcomes of apnea in infants with trisomy 18." | 3.96 | Management of apnea in infants with trisomy 18. ( Fujiyoshi, J; Ichimiya, Y; Inoue, H; Ochiai, M; Ohga, S; Sakai, Y; Sanefuji, M; Sawano, T; Taira, R; Torio, M, 2020) |
| "Many children with trisomy 18 have apneas from the neonatal period." | 3.81 | Apneas observed in trisomy 18 neonates should be differentiated from epileptic apneas. ( Asada, H; Fukasawa, T; Hattori, T; Kato, Y; Kubota, T; Matsusawa, K; Negoro, T; Tanaka, M, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ariagno, S | 1 |
| Thorvilson, M | 1 |
| Andersen, L | 1 |
| Collura, C | 1 |
| Smith, A | 1 |
| Egan, R | 1 |
| Boyle, MA | 1 |
| McElligott, F | 1 |
| Taira, R | 1 |
| Inoue, H | 1 |
| Sawano, T | 1 |
| Fujiyoshi, J | 1 |
| Ichimiya, Y | 1 |
| Torio, M | 1 |
| Sanefuji, M | 1 |
| Ochiai, M | 1 |
| Sakai, Y | 1 |
| Ohga, S | 1 |
| Fukasawa, T | 1 |
| Kubota, T | 1 |
| Tanaka, M | 1 |
| Asada, H | 1 |
| Matsusawa, K | 1 |
| Hattori, T | 1 |
| Kato, Y | 1 |
| Negoro, T | 1 |
4 other studies available for apnea and Complete Trisomy 18 Syndrome
| Article | Year |
|---|---|
Caffeine for the Treatment of Central Apnea in Trisomy 18: A Case Study in the Novel Use of Methylxanthines in Palliative Transport.
Topics: Apnea; Caffeine; Central Nervous System Stimulants; Female; Humans; Infant; Infant, Newborn; Infant, | 2022 |
The Use of Caffeine for Apnoea Associated with Trisomy 13 and Trisomy 18.
Topics: Apnea; Caffeine; Humans; Infant, Newborn; Infant, Premature; Trisomy 13 Syndrome; Trisomy 18 Syndrom | 2021 |
Management of apnea in infants with trisomy 18.
Topics: Apnea; Epilepsy; Female; Humans; Infant; Infant, Newborn; Intensive Care Units, Neonatal; Male; Outc | 2020 |
Apneas observed in trisomy 18 neonates should be differentiated from epileptic apneas.
Topics: Apnea; Child, Preschool; Chromosomes, Human, Pair 18; Diagnosis, Differential; Electroencephalograph | 2015 |